roomer

n.

房客，寄宿者；

Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C
Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis C
Optimizing Interferon Alfa Based Therapy for Chronic Hepatitis C
Current clinical care compared with new Dutch guidelines for hepatitis C treatment.
ARRANGEMENT FOR DISTRIBUTING STOCK EXCHANGE INFORMATION TO SUBSCRIBERS
Rationale and design of the virological response and ribavirin dosage (VIRID) study in hepatitis.
Erythropoietin administration suppresses human monocyte function in vitro and during therapy-induced anemia in HCV patients
ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection
Probabilistic facies discrimination from simultaneous seismic inversion results in clastics reservoir in southwest Venezuela
Alkaline hydrolytic lability of some hydroxy- and methoxycoumarins and related anticoagulants